Search Tag: Bladder Cancer

Decision Support

2025 22 May

  Lymphovascular invasion (LVI) is a critical prognostic marker in urothelial carcinoma of the bladder (UCB), associated with increased tumour aggressiveness, recurrence and lower survival rates. Conventionally, the presence of LVI is confirmed through immunohistochemical (IHC) staining, a method that, while accurate, is both time-consuming and...Read more

IMAGING Management

2025 29 Jan

  Bladder cancer (BCa) is one of the most common malignancies affecting the urinary tract. It requires careful histological grading, as treatment strategies differ significantly between low- and high-grade cases. High-grade BCa often carries a greater risk of recurrence and progression to muscle-invasive disease, while low-grade tumours tend to...Read more

IMAGING Management

2024 08 Sep

  Bladder cancer (BCa) is one of the most prevalent malignancies of the urinary system. A crucial distinction in BCa is whether it is muscle-invasive (MIBC) or non-muscle-invasive (NMIBC), as this classification significantly impacts treatment strategies and patient outcomes. Currently, invasive biopsy procedures and magnetic resonance imaging (MRI)...Read more

Executive Health Management

2024 03 Apr

<marquee behavior="slide" direction="left" scrollamount="30" style="text-align: center;"> <font color=#ff6600> Find ESMO On Social Media  </marquee> Read more

IT Management

2022 25 Apr

A small multisite study recently showed that artificial intelligence (AI) improved the ability of physicians to determine whether bladder cancer patients responded to chemotherapy before a radical cystectomy.   Establishing whether bladder cancer patients show a complete response to chemotherapy is important for determining whether the bladder...Read more

Executive Health Management

2020 15 Oct

Find Mirrors of Medicine on Social Media Read more

Executive Health Management

2020 21 Apr

A research predicts a decline in cancer mortality rates in 2020 in the EU. However, due to the COVID-19 pandemic cancer patient safety is compromised, but can still be improved with certain policies.   You may also like : Prostate is Now Most Common Cancer   Cancer in the EU Total cancer mortality rates in the...Read more

Executive Health Management

2019 25 Oct

Find Mirrors of Medicine on Social Media Read more

Executive Health Management

2018 20 Sep

Read more